Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial

Table 5 Means and standard deviation of proposed outcomes at baseline, post-MBCT and follow-up

Measured outcome	Condition	Baseline			Post-MBCT			6 month Follow up
Measured outcome	Condition	Mean	S.D.	N	Mean	S.D.	N	Mean	S.D.	N
BDI-II	MBCT	14.36	9.520	22	10.67	13.996	12	13.75	16.355	12
BDI-II	Wait-list	15.57	7.291	21	14.23	10.158	12	14.17	9.173	12
STAIY1	MBCT	38.76	11.397	21	37.74	15.635	12	39.67	16.183	12
STAIY1	Wait-list	37.26	10.429	20	43.67	5.806	12	45.16	9.347	12
STAIY2	MBCT	45.50	10.318	22	41.67	16.396	12	42.58	16.368	12
STAIY2	Wait-list	47.45	8.666	20	47.08	6.431	12	45.92	7.354	12
MAAS	MBCT	3.6586	.7935	22	4.2758	1.0342	12	4.1450	1.1675	12
MAAS	Wait-list	3.4005	.6655	22	3.5769	.5802	12	3.5433	.7867	12
CDAI	MBCT	101.56	60.28052	3	69.0000	86.15683	3	18.6833	15.01002	3
CDAI	Wait-list	145.866	84.76086	8	101.8750	66.69212	8	139.7150	83.44660	8
SCAI	MBCT	4.3750	2.77424	8	3.8750	3.39905	8	5.5000	4.17475	8
SCAI	Wait-list	2.2500	2.62996	4	4.5000	3.0000	4	5.0000	4.39697	4
IBDQ	MBCT	34.3333	12.17922	21	31.0833	18.0225	12	34.8333	23.7863	12
IBDQ	Wait-list	36.5714	14.40684	21	33.9167	15.1864	12	36.8333	12.0667	12

Depression (BDI-II); State anxiety (STAIY1); Trait anxiety (STAIY2); Dispositional mindfulness (MAAS); Crohn’s disease activity index (CDAI)
Ulcerative colitis activity index (SCAI); Disease specific QoL (IBDQ)

ISSN: 1745-6215